Although TLR4 signaling activated by neonatal inflammation does not contribute to acute opioid-induced respiratory depression in neonates (Zwicker et al., 2014), significant cross-talk between opioid receptors and inflammatory signaling pathways exists (reviewed in Zhang et al., 2020), which may explain some similarities in responses. This evidence concerns the gene TLR4 and respiratory depression.